KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Sales (2016 - 2025)

Historic Return on Sales for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to 0.15%.

  • Teva Pharmaceutical Industries' Return on Sales rose 2100.0% to 0.15% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.09%, marking a year-over-year increase of 1600.0%. This contributed to the annual value of 0.08% for FY2025, which is 2000.0% up from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Return on Sales stood at 0.15% for Q4 2025, which was up 2100.0% from 0.1% recorded in Q3 2025.
  • Teva Pharmaceutical Industries' Return on Sales' 5-year high stood at 0.15% during Q4 2025, with a 5-year trough of 0.4% in Q4 2023.
  • Moreover, its 5-year median value for Return on Sales was 0.01% (2021), whereas its average is 0.05%.
  • In the last 5 years, Teva Pharmaceutical Industries' Return on Sales surged by 12000bps in 2021 and then tumbled by -3100bps in 2022.
  • Over the past 5 years, Teva Pharmaceutical Industries' Return on Sales (Quarter) stood at 0.04% in 2021, then tumbled by -833bps to 0.34% in 2022, then decreased by -17bps to 0.4% in 2023, then skyrocketed by 84bps to 0.07% in 2024, then skyrocketed by 325bps to 0.15% in 2025.
  • Its last three reported values are 0.15% in Q4 2025, 0.1% for Q3 2025, and 0.07% during Q2 2025.